The anticoagulant and antithrombotic mechanisms of heparin

Handbook of Experimental Pharmacology
Elaine GrayB Mulloy

Abstract

The molecular basis for the anticoagulant action of heparin lies in its ability to bind to and enhance the inhibitory activity of the plasma protein antithrombin against several serine proteases of the coagulation system, most importantly factors IIa (thrombin), Xa and IXa. Two major mechanisms underlie heparin's potentiation of antithrombin. The conformational changes induced by heparin binding cause both expulsion of the reactive loop and exposure of exosites of the surface of antithrombin, which bind directly to the enzyme target; and a template mechanism exists in which both inhibitor and enzyme bind to the same heparin molecule. The relative importance of these two modes of action varies between enzymes. In addition, heparin can act through other serine protease inhibitors such as heparin co-factor II, protein C inhibitor and tissue factor plasminogen inhibitor. The antithrombotic action of heparin in vivo, though dominated by anticoagulant mechanisms, is more complex, and interactions with other plasma proteins and cells play significant roles in the living vasculature.

Citations

Jul 17, 2013·Marine Drugs·Nadezhda E UstyuzhaninaNikolay E Nifantiev
Jun 8, 2015·Glycoconjugate Journal·Kimie DateHaruko Ogawa
Mar 28, 2017·Journal of Pharmaceutical and Biomedical Analysis·Cynthia D SommersDavid A Keire
Aug 24, 2013·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Lin SuDingbao Chen
Mar 25, 2018·Chembiochem : a European Journal of Chemical Biology·Eduardo StancanelliMarco Guerrini
Jul 1, 2015·Journal of Neuro-oncology·Rosalie SchnoorMarike L D Broekman
Mar 15, 2015·Journal of Leukocyte Biology·Xiaofeng Wang, Marianna Kulka
Dec 18, 2013·Hämostaseologie·I AhrensA Zirlik
Aug 25, 2019·Nanomaterials·Trung Dinh NguyenYuri N Utkin
Nov 2, 2019·Cytometry. Part B, Clinical Cytometry·Benjamin E J Spurgeon, Khalid M Naseem
Apr 24, 2020·Current Opinion in Obstetrics & Gynecology·Rachel M CulliferTerri Huynh
Jul 17, 2020·Biomolecules·Katharina GerlingSandra Stoppelkamp
Dec 17, 2015·Pharmacological Reviews·Barbara MulloyClive P Page
Feb 19, 2013·Expert Review of Proteomics·Bernd GesslbauerAndreas J Kungl
Jul 27, 2017·Journal of Materials Science. Materials in Medicine·Alana Melo Dos SantosHelen Conceição Ferraz
Jul 28, 2019·Scientific Reports·Amrita PalBrent L Vernon
Jul 26, 2017·Drug Delivery and Translational Research·Manu Thomas KalathottukarenJayachandran N Kizhakkedathu
Jun 21, 2018·Clinical Journal of Gastroenterology·Prashanth RawlaVinaya Gaduputi
Apr 27, 2019·Frontiers in Bioengineering and Biotechnology·Francesco CopesDiego Mantovani
Nov 11, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Cinzia Lanzi, Giuliana Cassinelli
Jan 27, 2019·Journal of Cellular Physiology·Olivier DelézayXavier Delavenne
Apr 18, 2018·Pediatric Transplantation·Stylianos VoulgarelisJohn P Scott
Aug 18, 2020·The Journal of Surgical Research·John D EhrhardtAdel Elkbuli
Feb 28, 2020·Journal of the American Chemical Society·Laura Soria-MartinezMario Schelhaas
Aug 11, 2020·Pharmacology & Therapeutics·Claudia RiccardiDaniela Montesarchio
Apr 3, 2021·Frontiers in Molecular Biosciences·Changkai Bu, Lan Jin
Mar 28, 2021·European Journal of Clinical Investigation·Paulo Roberto Gabbai-ArmelinFernanda Lourenção Brighenti
May 1, 2021·Critical Reviews in Clinical Laboratory Sciences·G Lima-OliveiraP Ochoa
Aug 29, 2019·Biomacromolecules·Kim SilberreisJens Dernedde
Aug 24, 2021·Clinical Hemorheology and Microcirculation·Shuo ZhouAndreas Lendlein
Dec 17, 2019·Biomacromolecules·Abdullah Al NahainVito Ferro
Oct 6, 2021·Mass Spectrometry Reviews·Andreas ZappeKevin Pagel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.